| Bioactivity | Feniralstat (compound 30), a pyrazole derivative, is a potent kallikrein inhibitor with an IC50 of 6.7 nM for Human plasma kallikrein (pKal). Feniralstat has no inhibition on Human KLKl, Human FXIa, Human Factor Xlla (all IC50>40 μM). | |||||||||
| Name | Feniralstat | |||||||||
| CAS | 2166320-76-7 | |||||||||
| Formula | C26H25F2N5O4 | |||||||||
| Molar Mass | 509.50 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Rebecca Louise DAVIE, et al. Pyrazole derivatives as plasma kallikrein inhibitors. WO2017207983A1. |
Feniralstat
CAS: 2166320-76-7 F: C26H25F2N5O4 W: 509.50
Feniralstat (compound 30), a pyrazole derivative, is a potent kallikrein inhibitor with an IC50 of 6.7 nM for Human plas
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.